Production (Stage)
aTyr Pharma, Inc.
ATYR
$5.40
$0.09671.83%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.94% | -1.40% | -52.20% | -32.16% | -29.62% |
| Total Depreciation and Amortization | -50.26% | -100.25% | -60.93% | -34.64% | 1.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,076.12% | 194.74% | 144.76% | 96.68% | -133.67% |
| Change in Net Operating Assets | 79.23% | -53.96% | 223.84% | -26,476.47% | -172.95% |
| Cash from Operations | 31.10% | -18.71% | -37.65% | -70.27% | -3,693.22% |
| Capital Expenditure | -- | -47.06% | 97.31% | 99.67% | 98.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -230.10% | -134.02% | 263.58% | 479.28% | 96.37% |
| Cash from Investing | -225.96% | -134.15% | 309.45% | 261.89% | 96.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.26% | -11.30% | -15.74% | -17.14% | -83.33% |
| Issuance of Common Stock | 138.94% | 208.46% | -99.28% | 66.48% | -84.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 140.98% | 212.21% | -103.91% | 67.12% | -84.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 92.43% | -102.96% | 287.77% | 96.06% | -249.11% |